Coherus Oncology
CHRS
CHRS
176 hedge funds and large institutions have $572M invested in Coherus Oncology in 2022 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 74 increasing their positions, 53 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
11% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 27
41% less capital invested
Capital invested by funds: $975M → $572M (-$403M)
Holders
176
Holding in Top 10
–
Calls
$3.17M
Puts
$499K
Top Buyers
| 1 | +$8.83M | |
| 2 | +$7.81M | |
| 3 | +$6.43M | |
| 4 |
BlackRock
New York
|
+$5.87M |
| 5 |
TLP
Tri Locum Partners
New York
|
+$2.73M |
Top Sellers
| 1 | -$7.6M | |
| 2 | -$6.97M | |
| 3 | -$5.06M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.14M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$3.14M |